For research use only. Not for therapeutic Use.
Bcl-B inhibitor 1(Cat No.:I041084)is a selective small molecule designed to target and inhibit Bcl-B, a member of the Bcl-2 family of proteins involved in regulating apoptosis (programmed cell death). By blocking Bcl-B, the inhibitor promotes cell death in cancer cells and other disease states where Bcl-B’s anti-apoptotic function contributes to cell survival. This inhibition has shown promise in preclinical studies for enhancing the effectiveness of cancer treatments, particularly in overcoming resistance to chemotherapy. Bcl-B inhibitor 1 is a potential therapeutic agent for cancers and other disorders with aberrant apoptosis regulation.
CAS Number | 79220-88-5 |
Synonyms | N-[4-(5-phenyl-2-sulfanylidene-1H-imidazol-3-yl)phenyl]acetamide |
Molecular Formula | C17H15N3OS |
Purity | ≥95% |
IUPAC Name | N-[4-(5-phenyl-2-sulfanylidene-1H-imidazol-3-yl)phenyl]acetamide |
InChI | InChI=1S/C17H15N3OS/c1-12(21)18-14-7-9-15(10-8-14)20-11-16(19-17(20)22)13-5-3-2-4-6-13/h2-11H,1H3,(H,18,21)(H,19,22) |
InChIKey | ZCUQXYLNTJAWPQ-UHFFFAOYSA-N |
SMILES | CC(=O)NC1=CC=C(C=C1)N2C=C(NC2=S)C3=CC=CC=C3 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |